208
Views
0
CrossRef citations to date
0
Altmetric
LETTER

Limitations in the Use of Cystatin C as a Predictor of Major Adverse Cardiovascular Events: Consideration of Non-Renal Factors [Letter]

ORCID Icon & ORCID Icon
Pages 2555-2556 | Received 10 Jun 2023, Accepted 14 Jun 2023, Published online: 17 Jun 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.